Olopatadine Hydrochloride 45802-0104-01

Package NDC

45802-0104-01

Manufacturer: Padagis Israel Pharmaceuticals Ltd
Dosage Form: Spray
Route: Nasal
Product Type: Human Prescription Drug
Marketing Start: June 14, 2017
Listing Expires: December 31, 2026
Application: ANDA202853

Need to source Olopatadine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Olopatadine Hydrochloride	665 ug/1

Drug Class

Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]

Selected Package

45802-0104-01Selected

1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE